91 related articles for article (PubMed ID: 15261296)
1. Tubulin inhibitors. Synthesis and biological activity of HTI-286 analogs with B-segment heterosubstituents.
Niu C; Smith D; Zask A; Loganzo F; Discafani C; Beyer C; Greenberger L; Ayral-Kaloustian S
Bioorg Med Chem Lett; 2004 Aug; 14(16):4329-32. PubMed ID: 15261296
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and activity of novel analogs of hemiasterlin as inhibitors of tubulin polymerization: modification of the A segment.
Yamashita A; Norton EB; Kaplan JA; Niu C; Loganzo F; Hernandez R; Beyer CF; Annable T; Musto S; Discafani C; Zask A; Ayral-Kaloustian S
Bioorg Med Chem Lett; 2004 Nov; 14(21):5317-22. PubMed ID: 15454219
[TBL] [Abstract][Full Text] [Related]
3. D-piece modifications of the hemiasterlin analog HTI-286 produce potent tubulin inhibitors.
Zask A; Birnberg G; Cheung K; Kaplan J; Niu C; Norton E; Yamashita A; Beyer C; Krishnamurthy G; Greenberger LM; Loganzo F; Ayral-Kaloustian S
Bioorg Med Chem Lett; 2004 Aug; 14(16):4353-8. PubMed ID: 15261301
[TBL] [Abstract][Full Text] [Related]
4. Hybrids of the hemiasterlin analogue taltobulin and the dolastatins are potent antimicrotubule agents.
Zask A; Kaplan J; Musto S; Loganzo F
J Am Chem Soc; 2005 Dec; 127(50):17667-71. PubMed ID: 16351096
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of tubulysin D analogs related to stereoisomers of tubuvaline.
Shibue T; Okamoto I; Morita N; Morita H; Hirasawa Y; Hosoya T; Tamura O
Bioorg Med Chem Lett; 2011 Jan; 21(1):431-4. PubMed ID: 21106374
[TBL] [Abstract][Full Text] [Related]
6. Biophysical characterization of the interactions of HTI-286 with tubulin heterodimer and microtubules.
Krishnamurthy G; Cheng W; Lo MC; Aulabaugh A; Razinkov V; Ding W; Loganzo F; Zask A; Ellestad G
Biochemistry; 2003 Nov; 42(46):13484-95. PubMed ID: 14621994
[TBL] [Abstract][Full Text] [Related]
7. Absolute configurations of tubulin inhibitors taltobulin (HTI-286) and HTI-042 characterized by X-ray diffraction analysis and NMR studies.
Niu C; Ho DM; Williamson RT; Zask A; Ayral-Kaloustian S
Bioorg Med Chem Lett; 2010 Mar; 20(5):1535-8. PubMed ID: 20137930
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activity of analogues of the antimicrotubule agent N,beta,beta-trimethyl-L-phenylalanyl-N(1)-[(1S,2E)-3-carboxy-1-isopropylbut-2-enyl]- N(1),3-dimethyl-L-valinamide (HTI-286).
Zask A; Birnberg G; Cheung K; Kaplan J; Niu C; Norton E; Suayan R; Yamashita A; Cole D; Tang Z; Krishnamurthy G; Williamson R; Khafizova G; Musto S; Hernandez R; Annable T; Yang X; Discafani C; Beyer C; Greenberger LM; Loganzo F; Ayral-Kaloustian S
J Med Chem; 2004 Sep; 47(19):4774-86. PubMed ID: 15341492
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity and high-content imaging analyses of novel tubulysins.
Wang Z; McPherson PA; Raccor BS; Balachandran R; Zhu G; Day BW; Vogt A; Wipf P
Chem Biol Drug Des; 2007 Aug; 70(2):75-86. PubMed ID: 17683369
[TBL] [Abstract][Full Text] [Related]
10. Tumor cells resistant to a microtubule-depolymerizing hemiasterlin analogue, HTI-286, have mutations in alpha- or beta-tubulin and increased microtubule stability.
Poruchynsky MS; Kim JH; Nogales E; Annable T; Loganzo F; Greenberger LM; Sackett DL; Fojo T
Biochemistry; 2004 Nov; 43(44):13944-54. PubMed ID: 15518543
[TBL] [Abstract][Full Text] [Related]
11. Two photoaffinity analogues of the tripeptide, hemiasterlin, exclusively label alpha-tubulin.
Nunes M; Kaplan J; Wooters J; Hari M; Minnick AA; May MK; Shi C; Musto S; Beyer C; Krishnamurthy G; Qiu Y; Loganzo F; Ayral-Kaloustian S; Zask A; Greenberger LM
Biochemistry; 2005 May; 44(18):6844-57. PubMed ID: 15865430
[TBL] [Abstract][Full Text] [Related]
12. Probing the interaction of HTI-286 with tubulin using a stilbene analogue.
Lo MC; Aulabaugh A; Krishnamurthy G; Kaplan J; Zask A; Smith RP; Ellestad G
J Am Chem Soc; 2004 Aug; 126(32):9898-9. PubMed ID: 15303845
[TBL] [Abstract][Full Text] [Related]
13. Potent antitubulin tumor cell cytotoxins based on 3-aroyl indazoles.
Duan JX; Cai X; Meng F; Lan L; Hart C; Matteucci M
J Med Chem; 2007 Mar; 50(5):1001-6. PubMed ID: 17286393
[TBL] [Abstract][Full Text] [Related]
14. [4-(imidazol-1-yl)thiazol-2-yl]phenylamines. A novel class of highly potent colchicine site binding tubulin inhibitors: synthesis and cytotoxic activity on selected human cancer cell lines.
Mahboobi S; Sellmer A; Höcher H; Eichhorn E; Bär T; Schmidt M; Maier T; Stadlwieser JF; Beckers TL
J Med Chem; 2006 Sep; 49(19):5769-76. PubMed ID: 16970401
[TBL] [Abstract][Full Text] [Related]
15. New C5-alkylated indolobenzazepinones acting as inhibitors of tubulin polymerization: cytotoxic and antitumor activities.
Keller L; Beaumont S; Liu JM; Thoret S; Bignon JS; Wdzieczak-Bakala J; Dauban P; Dodd RH
J Med Chem; 2008 Jun; 51(12):3414-21. PubMed ID: 18503262
[TBL] [Abstract][Full Text] [Related]
16. New arylthioindoles: potent inhibitors of tubulin polymerization. 2. Structure-activity relationships and molecular modeling studies.
De Martino G; Edler MC; La Regina G; Coluccia A; Barbera MC; Barrow D; Nicholson RI; Chiosis G; Brancale A; Hamel E; Artico M; Silvestri R
J Med Chem; 2006 Feb; 49(3):947-54. PubMed ID: 16451061
[TBL] [Abstract][Full Text] [Related]
17. Sulfonate derivatives of naphtho[2,3-b]thiophen-4(9H)-one and 9(10H)-anthracenone as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
Zuse A; Schmidt P; Baasner S; Böhm KJ; Müller K; Gerlach M; Günther EG; Unger E; Prinz H
J Med Chem; 2007 Nov; 50(24):6059-66. PubMed ID: 17973361
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of 2- and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization.
Romagnoli R; Baraldi PG; Carrion MD; Lopez Cara C; Preti D; Fruttarolo F; Pavani MG; Tabrizi MA; Tolomeo M; Grimaudo S; Di Cristina A; Balzarini J; Hadfield JA; Brancale A; Hamel E
J Med Chem; 2007 May; 50(9):2273-7. PubMed ID: 17419607
[TBL] [Abstract][Full Text] [Related]
19. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41.
Pettit GR; Rhodes MR; Herald DL; Hamel E; Schmidt JM; Pettit RK
J Med Chem; 2005 Jun; 48(12):4087-99. PubMed ID: 15943482
[TBL] [Abstract][Full Text] [Related]
20. 9-Benzylidene-naphtho[2,3-b]thiophen-4-ones as novel antimicrotubule agents-synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
Zuse A; Schmidt P; Baasner S; Böhm KJ; Müller K; Gerlach M; Günther EG; Unger E; Prinz H
J Med Chem; 2006 Dec; 49(26):7816-25. PubMed ID: 17181164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
